Literature DB >> 27274712

Can anti-inflammatory medications improve symptoms and reduce mortality in schizophrenia?

Maju Mathew Koola1, Jeffrey K Raines2, Robert G Hamilton3, Robert P McMahon4.   

Abstract

Entities:  

Keywords:  anti-inflammatory medications; arterial compliance; cytokines; inflammation; mortality; schizophrenia; symptoms

Year:  2016        PMID： 27274712      PMCID： PMC4891974     

Source DB:  PubMed          Journal:  Curr Psychiatr        ISSN： 1537-8276


× No keyword cloud information.
  52 in total

Review 1.  Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease.

Authors:  Edward G Lakatta; Daniel Levy
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

2.  Simvastatin improved arterial compliance in high-risk patients.

Authors:  Gocha Saliashvili; Warren W Davis; Matthey T Harris; Ngoc-Anh Le; W Virgil Brown
Journal:  Vasc Endovascular Surg       Date:  2004 Nov-Dec       Impact factor: 1.089

3.  Total arterial compliance estimated by a novel method and all-cause mortality in the elderly: the PROTEGER study.

Authors:  Theodore G Papaioannou; Athanase D Protogerou; Nikolaos Stergiopulos; Orestis Vardoulis; Christodoulos Stefanadis; Michel Safar; Jacques Blacher
Journal:  Age (Dordr)       Date:  2014-05-07

4.  Reduction of the synaptophysin level but normal levels of glycerophospholipids in the gyrus cinguli in schizophrenia.

Authors:  Mikael Landén; Pia Davidsson; Carl-Gerhard Gottfries; Jan-Eric Månsson; Kaj Blennow
Journal:  Schizophr Res       Date:  2002-05-01       Impact factor: 4.939

5.  Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.

Authors:  Allison A Hedley; Cynthia L Ogden; Clifford L Johnson; Margaret D Carroll; Lester R Curtin; Katherine M Flegal
Journal:  JAMA       Date:  2004-06-16       Impact factor: 56.272

6.  Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review.

Authors:  Stéphane Potvin; Emmanuel Stip; Amir A Sepehry; Alain Gendron; Ramatoulaye Bah; Edouard Kouassi
Journal:  Biol Psychiatry       Date:  2007-11-19       Impact factor: 13.382

7.  Correlation of ultrasound-measured common carotid artery stiffness with pathological findings.

Authors:  T Wada; K Kodaira; K Fujishiro; K Maie; E Tsukiyama; T Fukumoto; T Uchida; S Yamazaki
Journal:  Arterioscler Thromb       Date:  1994-03

8.  Relationship of peripheral arterial compliance and standard cardiovascular risk factors.

Authors:  Howard J Willens; Warren Davis; David M Herrington; Karen Wade; Karen Kesler; Steve Mallon; W Virgil Brown; J H C Reiber; Jeffrey K Raines
Journal:  Vasc Endovascular Surg       Date:  2003 May-Jun       Impact factor: 1.089

9.  Anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis.

Authors:  Kaisa M Mäki-Petäjä; Maysoon Elkhawad; Joseph Cheriyan; Francis R Joshi; Andrew J K Ostör; Frances C Hall; James H F Rudd; Ian B Wilkinson
Journal:  Circulation       Date:  2012-10-24       Impact factor: 29.690

10.  Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states.

Authors:  Craig W Colton; Ronald W Manderscheid
Journal:  Prev Chronic Dis       Date:  2006-03-15       Impact factor: 2.830
View more
  4 in total

1.  Accumulation of Circulating Cell-Free CpG-Enriched Ribosomal DNA Fragments on the Background of High Endonuclease Activity of Blood Plasma in Schizophrenic Patients.

Authors:  E S Ershova; E M Jestkova; A V Martynov; G V Shmarina; P E Umriukhin; L V Bravve; N V Zakharova; G P Kostyuk; D V Saveliev; M D Orlova; M Bogush; S I Kutsev; N N Veiko; S V Kostyuk
Journal:  Int J Genomics       Date:  2019-08-05       Impact factor: 2.326

2.  Inflammatory Pathways in Psychiatric Disorders: The case of Schizophrenia and Depression.

Authors:  Tami Feng; Ashutosh Tripathi; Anilkumar Pillai
Journal:  Curr Behav Neurosci Rep       Date:  2020-07-26

3.  Peripheral Biomarkers for First-Episode Psychosis-Opportunities from the Neuroinflammatory Hypothesis of Schizophrenia.

Authors:  Nuno Trovão; Joana Prata; Orlando VonDoellinger; Susana Santos; Mário Barbosa; Rui Coelho
Journal:  Psychiatry Investig       Date:  2019-03-07       Impact factor: 2.505

Review 4.  Why Should Psychiatrists and Neuroscientists Worry about Paraoxonase 1?

Authors:  Estefania Gastaldello Moreira; Karine Maria Boll; Dalmo Guilherme Correia; Janaina Favaro Soares; Camila Rigobello; Michael Maes
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.